✦ LIBER ✦

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study

✍ Scribed by Bradley J. Monk; John A. Blessing; Daron G. Street; Carolyn Y. Muller; James J. Burke; Martee L. Hensley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib malate in the treatment of rec

✍ Martee L. Hensley; Michael W. Sill; Dennis R. Scribner Jr.; Jubilee Brown; Rober 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Phase II evaluation of liposomal doxorub

✍ Gregory Sutton; John Blessing; Parviz Hanjani; Paul Kramer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Trimetrexate in the Treatment of Recurre

✍ Harriet O. Smith; John A. Blessing; Luis Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase II evaluation of aflibercept in

✍ Robert L. Coleman; Michael W. Sill; Heather A. Lankes; Amanda Nickles Fader; Nei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Phase II Study of Mitomycin, Doxorubicin

✍ John H. Edmonson; John A. Blessing; Jonathan A. Cosin; David Scott Miller; David 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB